Comparative aspects of the pharmacology of the antimetabolites.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002642:Chick Embryo / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D004447:Echinodermata; D004625:Embryo, Nonmammalian / Q000187:drug effects; D005260:Female; D005467:Floxuridine / Q000633:toxicity; D006564:Herpesviridae / Q000187:drug effects; D007065:Idoxuridine / Q000494:pharmacology; D015122:Mercaptopurine / Q000633:toxicity; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects; D011743:Pyrimidines / Q000633:toxicity; D013045:Species Specificity; D013424:Sulfanilamides / Q000494:pharmacology; D013866:Thioguanine / Q000633:toxicity
D000963:Antimetabolites; D011743:Pyrimidines; D013424:Sulfanilamides; D005467:Floxuridine; D004247:DNA; D015122:Mercaptopurine; D013866:Thioguanine; D001973:Bromodeoxyuridine; D007065:Idoxuridine